BIO-key Q3 Software License Fees Grew 39%, Its Third Consecutive Quarter of Double-Digit Growth, Driven Primarily by Momentum in the Middle East and Europe; Hosts Call Today at 10am ET
BIO-key's Q3 Software License Fees Grew 39%, Its 3rd Consecutive Double-Digit Growth Quarter, Driven Primarily by Momentum in the Middle East and Europe.
Covered in this story
Call it yourself
No calls on $BIO yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Bio-Rad Laboratories →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.